HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) has raised alarm over the increasing incidence of HIV among young ...

Potential to revolutionize HIV prevention. Ethel Weld, an Assistant Professor of Medicine at Johns Hopkins University School ...

Lenacapavir, a new HIV prevention drug, has proven to dramatically reduce the risk of infection according to data reported ...

Young people living with HIV play a critical role in the fight against AIDS in communities. They offer support and share ...

Standard treatment of babies with HIV typically starts two to three months after birth and continues for decades. This new ...

The use of Pre-exposure Prophylasix (PrEP) has expanded significantly over the past few years contributing to reduction of new HIV infections.

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

There's a catch, however: Given as either a pill or injection and currently branded as Sunlenca, lenacapavir as treatment for ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...

With support from UNAIDS, two young social media influencers living with HIV are on their way to the United Nations General ...

The largest-ever study of women in sub-Saharan Africa zeroes in on the combination of bacterial vaginosis-associated bacteria ...